Management of non-malignant results in core needle biopsy of breast lesions

Zhao-qing FAN,Tao OUYANG,Jin-feng LI,Tian-feng WANG,Yun-tao XIE,Tie FAN,Zhe ZHANG,Ben-yao LIN
DOI: https://doi.org/10.3321/j.issn:0376-2491.2008.34.004
2008-01-01
Abstract:Objective To study the strategy of management of non-malignant results in core needle biopsy (CNB) of breast lesions. Methods Consecutive 2654 breast lesions underwent CNB with 14-gauge automated needles. 1130 lesions with diagnosis of non-malignant breast lesions examined by CNB were followed up. The histological diagnosis of CNB, subsequent excision or repeat CNB, and the follow-up for cases without repeat biopsy were studied. Results Among the 1130 non-malignant breast lesions examined by CNB, 530 underwent re-biopsy and 73 cases of carcinoma were found. 491 lesions were followed up for 1-38 months (median, 13.3 months) and another 4 cases of carcinoma were found during the follow-up. 109 cases were lost to follow-up. 57.9% (22/38) of the atypical ductal hyperplasia, 22.2% (4/18) of the atypical ductal cells, 27.9% (24/86) of the papillary lesions, and 90. 0% (9/10) of the suspicions carcinoma diagnosed by CNB were re-diagnosed as breast cancer finally. Conclusions Repeat biopsy is required for the high-risk lesions diagnosed by breast CNB. Excision can be avoided on the benign lesions whose CNB diagnosis is consistent with those by physical examination and imaging.
What problem does this paper attempt to address?